Sign in
CompletedNo phase

The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET

Key facts

Who runs it
Shandong University of Traditional Chinese Medicine
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
480 people enrolled
Started
15 Sept 2023
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Erzhi Tiangui Granule
  • Erzhi Tiangui Placebo
Record updated
13 April 2026

Who can take part

Age
35 years to 43 years
Sex
Women only
Healthy volunteers
Can take part
Show the full registry criteria (2)Hide the full registry criteria

Other criteria

  • Women aged 35 to 43 years with POR who were scheduled for IVF or intracytoplasmic sperm injection (ICSI) treatment were eligible for enrollment. The diagnosis of POR was based on the Bologna criteria
  • Women were excluded if they: (i) had a body mass index (BMI) ≥ 35 kg/m2; (ii) failed to obtain clinical pregnancy after three or more IVF/ICSI cycles; (iii) had a history of two or more recurrent pregnancy losses; (iv) were diagnosed with uterine abnormalities using hysteroscopy or diagnosed with hydrosalpinx using hysterosalpingography; (v) had a history of chemotherapy with cytotoxic agents, pelvic radiotherapy, or severe systemic diseases; (vi) had taken Chinese herbal medicines or other therapies affecting ovarian function within three months before study enrollment; or (vii) were allergic to the ingredients of EZTG granules or placebo

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized controlled trial aims to determine whether Erzhi Tiangui Formula can optimize the reproductive outcomes of elderly patients with expected poor ovarian response, and to provide a new approach to traditional Chinese medicine assisted in vitro fertilization and embryo transfer (IVF-ET).

The 2 groups in the trial

  • EZTG groupTreatment being tested

    Treatment: Erzhi Tiangui Granule

  • Control groupPlacebo, for comparison

    Treatment: Erzhi Tiangui Placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Erzhi Tiangui Granules on Live Birth Rate in Advanced-age Women With Poor Ovarian Response Undergoing in Vitro Fertilization: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Record updated
13 April 2026